Clinical trials
Age clinical trials
Below are recruiting age clinical trials, each written for real people, not researchers. We’re tracking 1,275 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07798700Recruiting
Biofluid research for brain and movement disorders
This study collects blood, spinal fluid, and other samples from people with brain or movement disorders, their family members, and healthy volunteers. The goal is to find better ways to diagnose and understand these conditions.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06091371Recruiting
Using a small implant for flatfoot in growing kids
This trial tests a new implant to treat flexible flatfoot in children. It may help reduce pain and improve foot function during growth.
BolognaAges 8–14 - NCT06539078Recruiting
How aging affects muscle mitochondria
This study looks at how aging affects muscle cells, especially mitochondria (the energy powerhouses in your cells). They are comparing people who are very inactive with those who are endurance athletes, in both young and middle-aged groups, to understand how exercise might slow age-related changes.
Amsterdam, North HollandAges 18–65 - NCT07776522RecruitingPhase 2
Gene therapy for wet age-related macular degeneration
This trial tests a one-time gene therapy injection under the retina for people with wet age-related macular degeneration (AMD), which causes blurry vision from abnormal blood vessels. It aims to reduce the need for frequent eye injections by delivering a treatment that may help the eye produce its own medicine.
Beijing, Beijing MunicipalityAges 50–85 - NCT07774000Recruiting
Cream for reducing facial wrinkles and other signs of aging
This study tests a cream containing a special form of vitamin B3 (called niacinamide riboside) to see if it can help reduce wrinkles, fine lines, and other signs of aging on the face. It might help your skin look smoother and more radiant.
Cape Town, Western CapeAges 30–60 - NCT06394232RecruitingPhase 1/Phase 2
Testing a cell therapy for advanced dry AMD with geographic atrophy
This trial tests a new treatment called Eyecyte-RPE™, made from special cells that support the retina. It is given as a single injection under the retina during eye surgery. The study aims to see if it can help people with advanced dry age-related macular degeneration (AMD) who have large areas of damage (geographic atrophy) in the center of their vision.
Jālna, MaharashtraAges 50–100 - NCT06621368Recruiting
Resistance training for healthy aging in older women
This study tests if two years of resistance exercise helps older women stay healthy and active. It's for postmenopausal women aged 60+ who are not currently exercising regularly.
Londrina, ParanáAges 60 years+ - NCT06540287Recruiting
Exercise study for healthy older adults
This study looks at how different levels of exercise affect health markers in older adults. It compares elite athletes to sedentary individuals to understand how exercise can improve health.
Novato, CaliforniaAges 65–80 - NCT07718347Recruiting
Growth-factor gel after laser for skin rejuvenation
This study tests a natural growth-factor solution applied after a laser treatment to improve skin's appearance. It may help you if you are a middle-aged adult with sun damage looking for enhanced healing and results from a laser procedure.
Sacramento, CaliforniaAges 40–70 - NCT07719049Recruiting
AI facial health check study for healthy adults
This study uses artificial intelligence to analyze facial photographs to see if health insights can be detected. It is for healthy adult volunteers and involves taking a photo of your face.
Boston, MassachusettsAges 18 years+ - NCT07707297Recruiting
Study of Navarre's Centenarians (born 1926-1927)
This study is for people aged 100 and older in Navarre, Spain. It aims to learn more about what contributes to a long and healthy life.
Pamplona, NavarreAges 100 years+ - NCT07695207RecruitingPhase 3
Testing SMZ1 with ranibizumab for wet macular degeneration
This trial tests a new medicine called SMZ1 combined with ranibizumab (a standard treatment) for people with wet macular degeneration. It may help improve vision by targeting the cause of the disease more effectively.
Seoul, SeoulAges 50 years+ - NCT06660706Recruiting
Exercise study for older adults with slow walking or weak grip
This study tests whether a supervised exercise program can help improve muscle strength and overall health in people aged 65 and older. It also looks for certain markers in the blood that may be linked to the benefits of exercise.
TaipeiAges 65 years+ - NCT06666660Recruiting
Multivitamin study for middle-aged adults
This trial tests whether taking a daily multivitamin and mineral supplement can slow or reverse biological aging in healthy middle-aged adults. It involves blood tests, wearing an OURA ring, and using a study app.
Singapore, SingaporeAges 40–60 - NCT07675200Recruiting
Miricell study on healthy aging and cell cleanup
This study tests whether a supplement called Miricell can improve markers of healthy aging and help your cells clean out damaged parts. If you are healthy, between 40 and 70 years old, and willing to follow a specific diet and visit schedule, you may be able to join.
Canfield, OhioAges 40–70 - NCT07676435RecruitingPhase 2
Fisetin trial for healthy lung aging
This study tests whether a natural supplement called fisetin can help slow lung decline in older adults who are either lifelong nonsmokers or long-term smokers. You would take fisetin or a placebo for a period and be monitored regularly.
Los Angeles, CaliforniaAges 60 years+ - NCT07674680RecruitingEarly Phase 1
Heart function study in women of different ages and body sizes
This trial tests how a drug affects heart function in women who have either a low or high body mass index (BMI). It aims to understand cardiovascular health differences across ages and body sizes.
Columbia, MissouriAges 18–70 - NCT07664280Recruiting
Facial acupuncture for skin aging
This study tests whether a single session of facial acupuncture can improve your skin's structure and how satisfied you are with your appearance. If you are concerned about facial aging and are in good general health, you may be able to join.
TaipeiAges 30–60 - NCT07660640Enrolling by invitation
Long-term follow-up for VOY-101 eye injection study
This study follows up with people who already received the VOY-101 injection for a type of age-related vision loss (non-neovascular age-related macular degeneration) in an earlier study. It checks how they are doing over a longer period of time.
Boston, MassachusettsAges 50 years+ - NCT06679296Recruiting
Aging and Memory Loss Study in China
This study looks at how aging affects memory and thinking. It uses brain scans, a spinal tap, and other tests to understand cognitive decline better.
Wenzhou, ZhejiangAges Any age - NCT07653269Recruiting
Tracking eye changes to predict AMD progression
This study uses eye imaging and other tests to predict if early age-related macular degeneration (AMD) will progress to a more advanced stage. It aims to help doctors identify who might need closer monitoring in the future.
SingaporeAges 55 years+ - NCT06141460RecruitingPhase 1/Phase 2
Gene therapy trial for wet age-related macular degeneration
This trial tests a new gene therapy called RRG001 for people with the 'wet' form of age-related macular degeneration. It aims to treat leaky blood vessels in the eye that can cause vision loss, possibly reducing the need for frequent eye injections.
Tianjin, Tianjin MunicipalityAges 50 years+ - NCT07642869Recruiting
Vitamins and minerals for healthy aging in middle-aged adults
This study tests whether taking a daily multivitamin and mineral supplement helps middle-aged adults stay healthier and more active as they age. Researchers will track changes in your fitness, energy, and overall wellness over the study period.
La Jolla, CaliforniaAges 40–60 - NCT07639203Recruiting
Brain training app for healthy aging
This trial tests a digital brain-training program designed to improve thinking skills like planning and memory in healthy older adults. It may help you stay sharp as you age.
Rovereto, TrentoAges 65–75
Hear when a new Age trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for age?
- Yes. Clin2 currently lists 1,275 recruiting age studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a age trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a age trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.